Alnylam Pharmaceuticals
ALNY
#756
Rank
NZ$58.40 B
Marketcap
NZ$436.49
Share price
0.34%
Change (1 day)
-44.13%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company